AN2 Therapeutics’ $70 Million Common Stock Offering

Leila Ahmed
Tagged:

Cooley advised AN2 Therapeutics, Inc., and Davis Polk & Wardwell advised the joint book-running managers on the offering.AN2 Therapeutics, Inc. (Nasdaq:ANTX) announced a SEC-registered follow-on offering…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now